Counsel Portfolio Services’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q2
$1.38M Buy
41,180
+2,077
+5% +$66.3K 0.14% 177
2016
Q1
$1.1M Hold
39,103
0.14% 139
2015
Q4
$1.2M Hold
39,103
0.13% 165
2015
Q3
$1.17M Hold
39,103
0.13% 171
2015
Q2
$1.24M Hold
39,103
0.13% 182
2015
Q1
$1.29M Hold
39,103
0.13% 179
2014
Q4
$1.16M Hold
39,103
0.12% 169
2014
Q3
$1.1M Buy
39,103
+4,532
+13% +$127K 0.11% 184
2014
Q2
$974K Sell
34,571
-19,815
-36% -$565K 0.09% 235
2014
Q1
$1.66M Sell
54,386
-47,256
-46% -$1.41M 0.17% 154
2013
Q4
$2.95M Sell
101,642
-10,637
-9% -$310K 0.3% 102
2013
Q3
$3.06K Buy
112,279
+13,168
+13% +$358K 0.15% 94
2013
Q2
$2.63M Buy
+99,111
New +$2.74M 0.32% 101

Other funds holding PFE

Counsel Portfolio Services's PFE Position: Q2 2016 in Review

Counsel Portfolio Services increased its Pfizer (PFE) stake by 5.3% in Q2 2016, buying an estimated $66.3K and bringing the position to 41,180 shares worth $1.38M. The position accounts for 0.14% of the portfolio, ranked #177.

Counsel Portfolio Services first reported a position in PFE in Q2 2013 and has held it in 13 quarters since. The position peaked at $2.95M in Q4 2013. 1,992 funds tracked by Wall St. Rank hold PFE as of Q2 2016.

  • Counsel Portfolio Services held 41,180 shares of Pfizer worth $1.38M as of Q2 2016.
  • Counsel Portfolio Services bought 2,077 Pfizer shares in Q2 2016, an estimated $66.3K.
  • Pfizer made up 0.14% of Counsel Portfolio Services's portfolio in Q2 2016, its #177 holding.
  • Counsel Portfolio Services first reported a position in Pfizer in Q2 2013 and has held it in 13 quarters since.
  • Counsel Portfolio Services's Pfizer position peaked at $2.95M in Q4 2013.
  • 1,992 funds tracked by Wall St. Rank held Pfizer as of Q2 2016.

Based on Counsel Portfolio Services's 13F filing for Q2 2016, filed 12 Aug 2016.